Reassessing withholding of statins during Paxlovid therapy: Is it worth risking loss of the pleiotropic effects of statins and cardiovascular protection?

Hannah Ariel, Amy Ricupero, John P. Cooke

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1204-1205
Number of pages2
JournalAmerican Journal of Health-System Pharmacy
Volume80
Issue number18
DOIs
StatePublished - Sep 15 2023

Keywords

  • COVID-19
  • Paxlovid
  • cardiovascular
  • pleiotropic
  • protection
  • statin

ASJC Scopus subject areas

  • Pharmacy
  • Pharmacology
  • Health Policy

Cite this